Filings
Finds words inside filing documents. Searching Alzamend Neuro, Inc.'s filings · 23 documents indexed.
6 documents · 43 matches
-
ALZN Alzamend Neuro, Inc. 10-K 2026-07-22
Item 16. Form 10-K Summary 67
material weakness in our internal control over financial reporting. If our remediation of this material weakness is not effective, or if we experience9 matches in this document -
ALZN Alzamend Neuro, Inc. 10-K 2025-07-22
Item 16. Form 10-K Summary 71
material weakness in our internal control over financial reporting. If our remediation of this material weakness is not effective, or if we experience13 matches in this document -
ALZN Alzamend Neuro, Inc. 10-Q 2026-09-10
Item 4. Controls and Procedures
weakness. The material weakness will not be considered to be remediated until the applicable remediated controls are operating for a sufficient6 matches in this document -
ALZN Alzamend Neuro, Inc. 10-Q 2026-03-11
Item 4. Controls and Procedures
weakness. The material weakness will not be considered to be remediated until the applicable remediated controls are operating for a sufficient5 matches in this document -
ALZN Alzamend Neuro, Inc. 10-Q 2025-12-09
Item 4. Controls and Procedures
weakness. The material weakness will not be considered to be remediated until the applicable remediated controls are operating for a sufficient5 matches in this document -
ALZN Alzamend Neuro, Inc. 10-Q 2025-09-10
Item 4. Controls and Procedures
weakness. The material weakness will not be considered to be remediated until the applicable remediated controls are operating for a sufficient5 matches in this document
Page 1 of 1 · 6 documents